BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/London
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/London
LAST-MODIFIED:20260721T092906Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260707T150000
DTEND;TZID=Europe/London:20260707T154500
DTSTAMP:20260812T220947Z
UID:{A0D9FBF6-6A44-4A34-B84A973CDE27B48A}
LOCATION:
SUMMARY:Live Q&A - Ask the Experts: From Preclinical to First-in-Human
DESCRIPTION:Transitioning from preclinical development into first-in-human studies is one of the most critical and complex stages in drug development. Early strategic decisions can significantly influence timelines, regulatory interactions, study success and overall programme progression.\n
 \n
 Join our live Q&A webinar to put your questions to experts who have seen and done it all, and gain practical insight into navigating the path from preclinical promise to clinical reality.\n
 \n
 Event details: https://www.bioindustry.org/events/our-events/live-qa-ask-the-experts-from-preclinical-to-first-in-human.html
PRIORITY:1
END:VEVENT
END:VCALENDAR